ATLASRevelation Biosciences (REVB) earnings date: Nov 5, 2026
Revelation Biosciences (REVB) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 5, 2026, after the close. Analysts expect EPS of -$6.16.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on REVB
| Last price | $4.03 (+7.5%) |
|---|---|
| Normal 1-day range (±1σ) | ±8.1% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Revelation Biosciences stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Revelation Biosciences reports on Nov 5, 2026. One email the day before, with ATLAS’s read on Revelation Biosciences. You can switch it off at any time.
Alert me before REVB reportsFree to start. Creating an account takes under a minute.
Notify me when Revelation Biosciences reports
Track REVB free Add Revelation Biosciences to a free ATLAS watchlist and see its next report date in one place.
REVB earnings at a glance
| Next report (confirmed) | Thu, Nov 5, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$6.16 |
| Last report | Aug 6, 2026 · Miss |
| Beat rate (last 5 reports) | 3 of 5 (60%) |
| Average EPS surprise | -5.1% |
| Average move around a report | ±4.0% (last 5) |
| Sector | Healthcare · Biotechnology |
Revelation Biosciences earnings history: last 5 reports
Revelation Biosciences last reported on Aug 6, 2026: EPS of -$6.09 against an estimate of -$5.81 (-4.8% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 6, 2026 | -$5.81 | -$6.09 | -4.8% | Miss | -0.9% |
| May 7, 2026 | -$8.05 | -$18.97 | -135.7% | Miss | -5.9% |
| Mar 17, 2026 | $0.42 | $0.65 | +54.8% | Beat | -1.6% |
| Feb 26, 2026 | -$25.62 | -$11.55 | +54.9% | Beat | -6.4% |
| Jan 15, 2026 | $2.98 | $3.14 | +5.4% | Beat | +5.4% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for REVB
See the fair value, the probability range and the earnings history of Revelation Biosciences on its ATLAS page.
Revelation Biosciences (REVB) stock analysisPlans from €3.99 a month.
Revelation Biosciences earnings: frequently asked questions
When does Revelation Biosciences (REVB) report earnings?
Revelation Biosciences is scheduled to report on Thursday, November 5, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for REVB?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$6.16 per share (USD). Estimates can change before the report.
How often does REVB beat earnings estimates?
Of its last 5 reports with a recorded result, Revelation Biosciences beat the EPS estimate 3 times; the average surprise was -5.1%. Past results do not predict the next one.
How much does REVB move around earnings?
Over its last 5 reports the stock moved an average of 4.0% (absolute, from the close before the report day to the close after it), and finished higher 1 of 5 times.
Did Revelation Biosciences beat earnings estimates last quarter?
Revelation Biosciences last reported on Aug 6, 2026: EPS of -$6.09 against an estimate of -$5.81 (-4.8% surprise), a miss.
How much does REVB usually move in a day?
On a normal trading day the ATLAS model puts REVB’s one-day range at about ±8.1%, with a 48% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 5, 2026
Educational information, not investment advice. Disclaimer